The announcement was a success, I have re-read. It is difficult to get overly worked up by it. The primary treatment piece failed but hey colorectal cancer would have sent SRX into a rocket. The liver cancer secondary treatment is strong, statistically significant. $28 or more TP completely justified IMHO but pls DYOR.
Roger Montgomery on Sirtex, page-83
-
- There are more pages in this discussion • 83 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.5¢ | $40.71K | 229.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 2141678 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 2268400 | 21 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| SRX (ASX) Chart |